Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Symptom severity scale of the DSM5 for schizophrenia, and other psychotic disorders: diagnostic validity and clinical feasibility.

Ritsner MS, Mar M, Arbitman M, Grinshpoon A.

Psychiatry Res. 2013 Jun 30;208(1):1-8. doi: 10.1016/j.psychres.2013.02.029. Epub 2013 Apr 10.

PMID:
23582209
2.
3.

Cross-sectional similarities and differences between schizophrenia, schizoaffective disorder and mania or mixed mania with mood-incongruent psychotic features.

Pini S, de Queiroz V, Dell'Osso L, Abelli M, Mastrocinque C, Saettoni M, Catena M, Cassano GB.

Eur Psychiatry. 2004 Feb;19(1):8-14.

PMID:
14969775
4.

A new rating scale for negative symptoms: the Motor-Affective-Social Scale.

Trémeau F, Goggin M, Antonius D, Czobor P, Hill V, Citrome L.

Psychiatry Res. 2008 Sep 30;160(3):346-55. doi: 10.1016/j.psychres.2007.06.021. Epub 2008 Aug 22.

PMID:
18722021
5.

Measuring cognitive insight in middle-aged and older patients with psychotic disorders.

Pedrelli P, McQuaid JR, Granholm E, Patterson TL, McClure F, Beck AT, Jeste DV.

Schizophr Res. 2004 Dec 1;71(2-3):297-305.

PMID:
15474900
6.

French version validation of the psychotic symptom rating scales (PSYRATS) for outpatients with persistent psychotic symptoms.

Favrod J, Rexhaj S, Ferrari P, Bardy S, Hayoz C, Morandi S, Bonsack C, Giuliani F.

BMC Psychiatry. 2012 Sep 28;12:161. doi: 10.1186/1471-244X-12-161.

7.

Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders.

Kao YC, Liu YP.

BMC Psychiatry. 2010 Aug 18;10:63. doi: 10.1186/1471-244X-10-63.

8.

Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia.

Apiquian R, Elena Ulloa R, Herrera-Estrella M, Moreno-Gómez A, Erosa S, Contreras V, Nicolini H.

Schizophr Res. 2009 Jul;112(1-3):181-6. doi: 10.1016/j.schres.2009.03.028. Epub 2009 Apr 23.

PMID:
19398302
10.

Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz).

Suzuki T, Uchida H, Nomura K, Takeuchi H, Nakajima S, Tanabe A, Yagi G, Watanabe K, Kashima H.

Schizophr Res. 2008 Dec;106(2-3):328-36. doi: 10.1016/j.schres.2008.08.013. Epub 2008 Sep 19.

PMID:
18804960
11.

SCID-PANSS: two-tier diagnostic system for psychotic disorders.

Kay SR, Opler LA, Spitzer RL, Williams JB, Fiszbein A, Gorelick A.

Compr Psychiatry. 1991 Jul-Aug;32(4):355-61.

PMID:
1935026
12.

Factor structure and external validity of the PANSS revisited.

Van den Oord EJ, Rujescu D, Robles JR, Giegling I, Birrell C, Bukszár J, Murrelle L, Möller HJ, Middleton L, Muglia P.

Schizophr Res. 2006 Feb 28;82(2-3):213-23. Epub 2005 Oct 17.

PMID:
16229988
13.

Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders.

Purnine DM, Carey KB, Maisto SA, Carey MP.

J Nerv Ment Dis. 2000 Oct;188(10):653-61.

PMID:
11048814
14.

The Portuguese version of the Clinical Global Impression-Schizophrenia Scale: validation study.

Lima MS, Soares BG, Paoliello G, Machado Vieira R, Martins CM, Mota Neto JI, Ferrão Y, Schirmer DA, Volpe FM.

Rev Bras Psiquiatr. 2007 Sep;29(3):246-9.

15.

Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.

Peralta V, Cuesta MJ.

J Affect Disord. 2008 May;108(1-2):71-86. Epub 2007 Oct 29.

PMID:
18029027
16.

Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.

Sarró S, Dueñas RM, Ramírez N, Arranz B, Martínez R, Sánchez JM, González JM, Saló L, Miralles L, San L.

Schizophr Res. 2004 Jun 1;68(2-3):349-56. Erratum in: Schizophr Res. 2994 Oct 1;70(2-3):345.

PMID:
15099616
17.

Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients.

Katz G, Durst R, Shufman E, Bar-Hamburger R, Grunhaus L.

Compr Psychiatry. 2010 Jan-Feb;51(1):37-41. doi: 10.1016/j.comppsych.2009.03.008. Epub 2009 May 6.

PMID:
19932824
18.

The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice.

García-Campayo J, Zamorano E, Ruiz MA, Pérez-Páramo M, López-Gómez V, Rejas J.

Health Qual Life Outcomes. 2012 Sep 19;10:114. doi: 10.1186/1477-7525-10-114.

19.

The Beck Cognitive Insight Scale in outpatients with psychotic disorders: further evidence from a French-speaking sample.

Favrod J, Zimmermann G, Raffard S, Pomini V, Khazaal Y.

Can J Psychiatry. 2008 Nov;53(11):783-7.

PMID:
19087473
20.

DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication.

Peralta V, Campos MS, de Jalon EG, Cuesta MJ.

Schizophr Res. 2010 May;118(1-3):168-75. doi: 10.1016/j.schres.2009.12.023. Epub 2010 Jan 13.

PMID:
20071147
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk